BridgeBio Pharma LLC 13D/13G Filings for

BridgeBio Pharma LLC 13D and 13G filings for :

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2025-08-18
5:41 pm
Purchase		2025-08-1113DHelix Acquisition Corp. II
HLXB		BridgeBio Pharma LLC13,878,554
17.500%		13,878,554increase
(New Position)		Filing